The FDA approves Ionis' Zanvastro as the first treatment for Alexander disease, clearing the way for the company's first solo neurology launch.

Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.

Zilganersen targets protein buildup that drives Alexander disease